• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

从20种肿瘤类型中鉴定铜死亡相关的预后基因表达特征

Identification of Cuproptosis-Associated Prognostic Gene Expression Signatures from 20 Tumor Types.

作者信息

Ooko Ednah, Ali Nadeen T, Efferth Thomas

机构信息

Laboratory of Cell Biology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.

Department of Biological Sciences, School of Natural and Applied Sciences, Masinde Muliro University of Science and Technology, Kakamega 190-50100, Kenya.

出版信息

Biology (Basel). 2024 Oct 3;13(10):793. doi: 10.3390/biology13100793.

DOI:10.3390/biology13100793
PMID:39452102
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11505359/
Abstract

We investigated the mRNA expression of 124 cuproptosis-associated genes in 7489 biopsies from 20 different tumor types of The Cancer Genome Atlas (TCGA). The KM plotter algorithm has been used to calculate Kaplan-Meier statistics and false discovery rate (FDR) corrections. Interaction networks have been generated using Ingenuity Pathway Analysis (IPA). High mRNA expression of 63 out of 124 genes significantly correlated with shorter survival times of cancer patients across all 20 tumor types. IPA analyses revealed that their gene products were interconnected in canonical pathways (e.g., cancer, cell death, cell cycle, cell signaling). Four tumor entities showed a higher accumulation of genes than the other cancer types, i.e., renal clear cell carcinoma ( = 21), renal papillary carcinoma ( = 13), kidney hepatocellular carcinoma ( = 13), and lung adenocarcinoma ( = 9). These gene clusters may serve as prognostic signatures for patient survival. These signatures were also of prognostic value for tumors with high mutational rates and neoantigen loads. Cuproptosis is of prognostic significance for the survival of cancer patients. The identification of specific gene signatures deserves further exploration for their clinical utility in routine diagnostics.

摘要

我们研究了来自癌症基因组图谱(TCGA)中20种不同肿瘤类型的7489份活检样本中124个铜死亡相关基因的mRNA表达情况。使用KM plotter算法计算了Kaplan-Meier统计量和错误发现率(FDR)校正值。利用 Ingenuity 通路分析(IPA)生成了相互作用网络。在所有20种肿瘤类型中,124个基因中有63个基因的高mRNA表达与癌症患者较短的生存时间显著相关。IPA分析显示,它们的基因产物在经典通路(如癌症、细胞死亡、细胞周期、细胞信号传导)中相互关联。四种肿瘤实体显示出比其他癌症类型更多的基因积累,即肾透明细胞癌(= 21)、肾乳头状癌(= 13)、肾肝细胞癌(= 13)和肺腺癌(= 9)。这些基因簇可作为患者生存的预后标志物。这些标志物对具有高突变率和新抗原负荷的肿瘤也具有预后价值。铜死亡对癌症患者的生存具有预后意义。鉴定特定的基因标志物在常规诊断中的临床应用值得进一步探索。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9356/11505359/487369354154/biology-13-00793-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9356/11505359/93d49f1fb1aa/biology-13-00793-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9356/11505359/481e256ef2ca/biology-13-00793-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9356/11505359/97cd4c938850/biology-13-00793-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9356/11505359/487369354154/biology-13-00793-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9356/11505359/93d49f1fb1aa/biology-13-00793-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9356/11505359/481e256ef2ca/biology-13-00793-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9356/11505359/97cd4c938850/biology-13-00793-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9356/11505359/487369354154/biology-13-00793-g004.jpg

相似文献

1
Identification of Cuproptosis-Associated Prognostic Gene Expression Signatures from 20 Tumor Types.从20种肿瘤类型中鉴定铜死亡相关的预后基因表达特征
Biology (Basel). 2024 Oct 3;13(10):793. doi: 10.3390/biology13100793.
2
A Cuproptosis-Related LncRNA Risk Model for Predicting Prognosis and Immunotherapeutic Efficacy in Patients with Hepatocellular Carcinoma.铜死亡相关长链非编码 RNA 风险模型预测肝细胞癌患者的预后和免疫治疗疗效。
Biochem Genet. 2024 Jun;62(3):2332-2351. doi: 10.1007/s10528-023-10539-x. Epub 2023 Oct 29.
3
Cuproptosis-Related LncRNA-Based Prediction of the Prognosis and Immunotherapy Response in Papillary Renal Cell Carcinoma.基于铜死亡相关长链非编码 RNA 的预测在乳头状肾细胞癌中的预后和免疫治疗反应。
Int J Mol Sci. 2023 Jan 11;24(2):1464. doi: 10.3390/ijms24021464.
4
Multi-omics pan-cancer study of cuproptosis core gene and its role in kidney renal clear cell carcinoma.泛癌多组学研究铜死亡核心基因及其在肾透明细胞癌中的作用。
Front Immunol. 2022 Dec 20;13:981764. doi: 10.3389/fimmu.2022.981764. eCollection 2022.
5
Clinical significance and immune landscape of cuproptosis-related lncRNAs in kidney renal clear cell carcinoma: a bioinformatical analysis.肾透明细胞癌中铜死亡相关长链非编码RNA的临床意义及免疫图谱:一项生物信息学分析
Ann Transl Med. 2022 Nov;10(22):1235. doi: 10.21037/atm-22-5204.
6
Identification and Validation of Cuproptosis-Related LncRNA Signatures in the Prognosis and Immunotherapy of Clear Cell Renal Cell Carcinoma Using Machine Learning.基于机器学习的铜死亡相关 lncRNA 标志物在透明细胞肾细胞癌预后和免疫治疗中的鉴定和验证。
Biomolecules. 2022 Dec 16;12(12):1890. doi: 10.3390/biom12121890.
7
Prognostic and Immunological Significance of the Molecular Subtypes and Risk Signatures Based on Cuproptosis in Hepatocellular Carcinoma.基于铜死亡的肝细胞癌分子亚型和风险特征的预后和免疫意义。
Mediators Inflamm. 2023 Apr 20;2023:3951940. doi: 10.1155/2023/3951940. eCollection 2023.
8
Cuproptosis-related molecular classification and gene signature of hepatocellular carcinoma and experimental verification.肝细胞癌的铜死亡相关分子分类及基因特征与实验验证
Transl Cancer Res. 2024 Mar 31;13(3):1268-1289. doi: 10.21037/tcr-23-1876. Epub 2024 Mar 27.
9
An integrative analysis revealing cuproptosis-related lncRNAs signature as a novel prognostic biomarker in hepatocellular carcinoma.一项综合分析揭示铜死亡相关长链非编码RNA特征作为肝细胞癌的一种新型预后生物标志物。
Front Genet. 2023 Feb 10;14:1056000. doi: 10.3389/fgene.2023.1056000. eCollection 2023.
10
Signature construction and molecular subtype identification based on cuproptosis-related genes to predict the prognosis and immune activity of patients with hepatocellular carcinoma.基于铜死亡相关基因的signature 构建和分子亚型鉴定,预测肝细胞癌患者的预后和免疫活性。
Front Immunol. 2022 Sep 28;13:990790. doi: 10.3389/fimmu.2022.990790. eCollection 2022.

引用本文的文献

1
p53 enhances elesclomol-Cu-induced cuproptosis in hepatocellular carcinoma via FDXR-mediated FDX1 upregulation.p53通过FDXR介导的FDX1上调增强依斯氯铵-Cu诱导的肝癌细胞铜死亡。
Front Oncol. 2025 Jun 24;15:1584811. doi: 10.3389/fonc.2025.1584811. eCollection 2025.

本文引用的文献

1
Cuproptosis in lung cancer: therapeutic options and prognostic models.铜死亡在肺癌中的作用:治疗选择和预后模型。
Apoptosis. 2024 Oct;29(9-10):1393-1398. doi: 10.1007/s10495-024-01978-x. Epub 2024 May 12.
2
Integrated analysis of public datasets for the discovery and validation of survival-associated genes in solid tumors.整合公共数据集以发现和验证实体瘤中与生存相关的基因
Innovation (Camb). 2024 Apr 9;5(3):100625. doi: 10.1016/j.xinn.2024.100625. eCollection 2024 May 6.
3
A novel TCGA-validated programmed cell-death-related signature of ovarian cancer.
一种经TCGA验证的卵巢癌程序性细胞死亡相关特征。
BMC Cancer. 2024 Apr 23;24(1):515. doi: 10.1186/s12885-024-12245-2.
4
Targeting cuproplasia and cuproptosis in cancer.靶向癌症中的铜稳态和铜死亡。
Nat Rev Clin Oncol. 2024 May;21(5):370-388. doi: 10.1038/s41571-024-00876-0. Epub 2024 Mar 14.
5
Construction of a New Ferroptosis-related Prognosis Model for Survival Prediction in Colorectal Cancer.构建用于预测结直肠癌生存的新型铁死亡相关预后模型
Curr Med Chem. 2024 Feb 14. doi: 10.2174/0109298673296767240116215814.
6
Network pharmacology: towards the artificial intelligence-based precision traditional Chinese medicine.网络药理学:迈向基于人工智能的精准中医药。
Brief Bioinform. 2023 Nov 22;25(1). doi: 10.1093/bib/bbad518.
7
Construction of a ferroptosis-based prognostic model for breast cancer helps to discriminate high/low risk groups and treatment priority.构建基于铁死亡的乳腺癌预后模型有助于区分高/低风险组和治疗优先级。
Front Immunol. 2023 Dec 13;14:1264206. doi: 10.3389/fimmu.2023.1264206. eCollection 2023.
8
Transcriptome-level discovery of survival-associated biomarkers and therapy targets in non-small-cell lung cancer.非小细胞肺癌中与生存相关的生物标志物和治疗靶点的转录组水平发现。
Br J Pharmacol. 2024 Feb;181(3):362-374. doi: 10.1111/bph.16257. Epub 2023 Nov 23.
9
Identification of cuproptosis and immune-related gene prognostic signature in lung adenocarcinoma.肺腺癌中铜死亡和免疫相关基因预后特征的鉴定。
Front Immunol. 2023 Aug 9;14:1179742. doi: 10.3389/fimmu.2023.1179742. eCollection 2023.
10
The therapeutic potential of targeting regulated non-apoptotic cell death.靶向调控非细胞凋亡性细胞死亡的治疗潜力。
Nat Rev Drug Discov. 2023 Sep;22(9):723-742. doi: 10.1038/s41573-023-00749-8. Epub 2023 Aug 7.